30年来内分泌硬化药物首次下降的费用,使治疗更加容易获得。 Cost of endometriosis drug drops for first time in 30 years, making treatment more accessible.

一项新的发展导致用于治疗内分泌硬化的药物的成本大幅降低,标志着30年来价格首次下降。 A new development has led to a significant reduction in the cost of a drug used to treat endometriosis, marking the first price decrease in 30 years. 这种改善可以使许多患者更容易获得治疗。 This improvement could make treatment more accessible to many patients struggling with the condition.